Literature DB >> 1854612

Defective erythropoiesis in primary myelofibrosis associated with a chromosome 11 abnormality.

W N Patton1, C M Bunce, S Larkins, G Brown.   

Abstract

A case of primary myelofibrosis was identified with a previously unreported complex karyotype with two abnormal clones in addition to a proportion of normal cells: 46,XY,-2,-11, + der(2)t(2;11) (q24/31;q13), + mar and 45,XY,-2,-11, + der(2)t(2;11)(q24/31;q13), + mar, -17, del(7q). Study of circulating committed progenitors from this patient consistently showed (1) an absence of erythroid progenitors which is uncommon and (2) greatly increased granulocyte-monocyte progenitors (CFU-GM) which is generally observed in myelofibrosis. Further study showed that peripheral blood mononuclear cells co-cultured with irradiated normal bone marrow stroma generated increased numbers of CFU-GM compared with controls but failed to generate erythroid progenitors, providing evidence for an intrinsic defect in erythropoiesis. Only once previously has the absence of erythroid progenitors in primary myelofibrosis been studied in relation to cytogenetic abnormalities. This case also revealed a complex karyotype which, however, shared with our case a defect on chromosome 11. The identification of two cases of primary myelofibrosis which lack committed erythroid progenitor cells and which show in common a chromosomal defect on chromosome 11 point to the existence of genes on this chromosome which play a key role during erythropoiesis.

Entities:  

Mesh:

Year:  1991        PMID: 1854612      PMCID: PMC1977306          DOI: 10.1038/bjc.1991.255

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Erythroid hypoplasia in myelofibrosis: a feature associated with blastic transformation.

Authors:  S A Bentley; K H Murray; S M Lewis; P D Roberts
Journal:  Br J Haematol       Date:  1977-05       Impact factor: 6.998

2.  Multilineage expression of haemopoietic precursors with an abnormal clone in idiopathic myelofibrosis.

Authors:  Y Sato; T Suda; J Suda; A Ohsaka; K Kubota; M Saito; Y Miura
Journal:  Br J Haematol       Date:  1986-12       Impact factor: 6.998

3.  Effects of recombinant alpha and gamma interferons on the in vitro growth of circulating hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM) from patients with myelofibrosis with myeloid metaplasia.

Authors:  C Carlo-Stella; M Cazzola; A Gasner; G Barosi; L Dezza; F Meloni; P Pedrazzoli; D Hoelzer; E Ascari
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

4.  Cytogenetic evidence for a clonal disorder involving CFU-GEMM, BFU-E and CFU-C in patients with myeloproliferative disorders.

Authors:  H Sugiyama; S Ichiba; Y Okuno; T Takahashi; H Imura; K Nakamura; S Iho; T Hoshino; T Okada; H Furukawa
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1989-09

5.  Deletions of chromosome 13 in malignant hematologic disorders.

Authors:  D D Johnson; G W Dewald; R V Pierre; L Letendre; M N Silverstein
Journal:  Cancer Genet Cytogenet       Date:  1985-11

6.  Blood and spleen haematopoiesis in patients with myelofibrosis.

Authors:  L Douay; J P Laporte; G Lefrancois; A Najman; M C Dupuy-Montbrun; M Lopez; M C Giarratana; N C Gorin
Journal:  Leuk Res       Date:  1987       Impact factor: 3.156

7.  Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis.

Authors:  R J Jacobson; A Salo; P J Fialkow
Journal:  Blood       Date:  1978-02       Impact factor: 22.113

8.  Coincidence between fragile site expression and interstitial deletion of chromosome 11 in a case of myelofibrosis.

Authors:  M Sessarego; F Ajmar; R Ravazzolo; G L Bianchi Scarrà; C Garrè; P Boccaccio
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

9.  Differences among myeloproliferative disorders in the behavior of their restricted progenitor cells in culture.

Authors:  H Croizat; D Amato; D L McLeod; D Eskinazi; A A Axelrad
Journal:  Blood       Date:  1983-09       Impact factor: 22.113

10.  Red cell aplasia in myelofibrosis with myeloid metaplasia. A distinct functional and clinical entity.

Authors:  G Barosi; A Baraldi; M Cazzola; P Spriano; U Magrini
Journal:  Cancer       Date:  1983-10-01       Impact factor: 6.860

View more
  1 in total

1.  Defective erythropoiesis in myelodysplastic syndromes.

Authors:  W N Patton; C M Bunce; G Brown; S Larkin
Journal:  J Clin Pathol       Date:  1991-11       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.